ribavirin has been researched along with paclitaxel in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 12 (52.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bao, J; He, F; Qi, SH; Shi, YM; Tu, ZC; Zhang, XY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Agudelo-Gomez, LS; Betancur-Galvis, LA; Brand, YM; Gallego-Gomez, JC; González, MA; Roa-Linares, VC; Tangarife-Castaño, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, R; Chen, X; Dai, J; Feng, J; Li, Y; Liu, J; Tan, Z; Xie, K; Yu, L; Zhang, D; Zhao, J | 1 |
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
Black, P; Bryant, L; Goh, K | 1 |
Olah, E; Sledge, GW; Weber, G; Wendel, JJ; Yeh, YA | 1 |
Monden, Y; Prajda, N; Taniki, T; Weber, G | 1 |
Weber, G; Yeh, YA | 1 |
Babó, I; Harisi, R; Jeney, A; Kenessey, I; Oláh, J; Pogány, G; Timár, F | 1 |
Chen, H; Dai, D; Tang, J; Tang, Y | 1 |
Dai, X; Li, L; Liu, D; Shen, X; Xiao, B; Xiao, Z; Zhu, Y | 1 |
Dunn, LA; Fury, MG; Haque, SS; Ho, AA; Katabi, N; Pfister, DG; Sherman, EJ | 1 |
Cao, L; Gong, Z; Wang, L; Xi, C; Ye, H; Yu, J | 1 |
3 review(s) available for ribavirin and paclitaxel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
[Study of drugs against neoplastic metastasis].
Topics: Animals; Antineoplastic Agents; Cell Movement; Chromones; Deoxyuridine; Doxorubicin; Enzyme Inhibitors; Fatty Alcohols; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Morpholines; Neoplasm Metastasis; Paclitaxel; Pyridines; Ribavirin; Signal Transduction; Sirolimus | 2006 |
1 trial(s) available for ribavirin and paclitaxel
Article | Year |
---|---|
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.
Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin | 2018 |
19 other study(ies) available for ribavirin and paclitaxel
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162.
Topics: 4-Butyrolactone; Alkaloids; Antineoplastic Agents; Antiviral Agents; Aspergillus; China; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Anti-herpetic and anti-dengue activity of abietane ferruginol analogues synthesized from (+)-dehydroabietylamine.
Topics: Abietanes; Antiviral Agents; Dengue Virus; Dose-Response Relationship, Drug; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2016 |
Stachybotrysins A-G, Phenylspirodrimane Derivatives from the Fungus Stachybotrys chartarum.
Topics: Anti-HIV Agents; Antiviral Agents; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Influenza A virus; Inhibitory Concentration 50; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polycyclic Sesquiterpenes; Sesquiterpenes; Spiro Compounds; Stachybotrys; Structure-Activity Relationship | 2017 |
Guidelines for the use of expensive medicines.
Topics: Drug Costs; Drug Utilization; Granulocyte Colony-Stimulating Factor; Humans; New Zealand; Paclitaxel; Pharmacy Service, Hospital; Ribavirin | 1995 |
Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: schedule-dependence.
Topics: Cell Division; Drug Synergism; Female; Humans; Methotrexate; Paclitaxel; Ribavirin; Tumor Cells, Cultured | 1994 |
Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Adenosquamous; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Rats; Ribavirin; Spindle Apparatus; Tumor Cells, Cultured | 1993 |
Growth inhibitory action of brefeldin A with taxol and tiazofurin in human breast carcinoma cells.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Brefeldin A; Cell Division; Cyclopentanes; Drug Synergism; Humans; Macrolides; Paclitaxel; Ribavirin; Tumor Cells, Cultured | 1995 |
Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma.
Topics: Animals; Antimetabolites; Antiviral Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Nucleocytoplasmic Transport Proteins; Paclitaxel; Ribavirin; Signal Transduction; Tongue Neoplasms; TOR Serine-Threonine Kinases | 2017 |
Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, SCID; Paclitaxel; Ribavirin; Signal Transduction; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Drug Resistance; Drug Synergism; Eukaryotic Initiation Factor-4E; Female; Fluorouracil; Humans; Mice; Paclitaxel; Ribavirin; Uterine Cervical Neoplasms | 2018 |